Research LettersTransmission of glioblastoma multiforme through liver transplantation
References (5)
- et al.
CD44 splice variants: metastases meet lymphocytes
Immunol Today
(1993) Malignancy in transplanted organs
Transpl Int
(1993)
Cited by (66)
Donors risk assessment in transplantation: From the guidelines to their real-world application
2024, Pathology Research and PracticeOrgan Donation and Primary Central Nervous System Tumors
2020, Transplantation ProceedingsCitation Excerpt :Presumably, for none of these donors was there evidence of active neoplasia except from donors with carcinoma (basal cell or squamous cell) of the skin or with primary CNS tumors. Of the donors with primary CNS tumors, 1 of them had a glioblastoma that was fatally transmitted in 3 organ receptors (lung, liver, and kidney) [5–11]. Gliomas constitute half of all CNS tumors at all ages, followed by meningioma (15%-20%), pituitary adenomas (10%), neurinomas (8%), hemangioblastomas (2%), and tumors of the pineal region and others (1%) [5].
Organ transplantation from donors (cadaveric or living) with a history of malignancy: Review of the literature
2014, Transplantation ReviewsCitation Excerpt :According to the study, 4 recipients were confirmed to have donor-transmitted lymphoma and two of them died as the result of lymphoma transmission [9]. In addition to lymphoma, acute promyelocytic leukemia has been transferred by the transplantation of a cadaveric liver allograft [51], metastatic glioblastoma multiforme has been transferred in kidney and liver transplants [52,53], and acute myeloid leukemia has been transmitted by the transplantation of donor bone marrow [54]. In 2008, Harbell et al. reported a case of anaplastic T-cell lymphoma transmitted to four recipients of solid organ transplants from a DCD donor suspected of having bacterial meningitis [55].
Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities
2013, Biology of Blood and Marrow TransplantationCitation Excerpt :Older donors are also more likely to have underlying medical conditions, which increase the risk of transmitting a disorder from the donor to the recipient. The transmission of disease from a BMT donor to recipient is rare but well documented, and diseases that may be transmitted by BMT include genetic disorders, infections, autoimmune diseases, and both hematologic and nonhematologic malignancies [3-11]. Although once thought to be a rare occurrence, “donor cell leukemia” is being reported with increased frequency, with recent estimates suggesting it may account for up to 5% of all leukemia “relapses” [12-18].
Skeletal spread of an anaplastic astrocytoma (WHO grade III) and preservation of histopathological properties within metastases
2013, Clinical Neurology and NeurosurgeryCitation Excerpt :There are several reports on patients who received a ventriculoperitoneal (VP) shunt and developed metastases in the peritoneal cavity [30,31]. In addition, there have been several published cases of distant metastases of patients who underwent organ transplantation [32–34]. The question of whether organ donors with malignant brain tumours are acceptable is not yet fully resolved.
Cancer in Dialysis and Renal Transplant Patients
2008, Kidney Transplantation: Principles and Practice